Related references
Note: Only part of the references are listed.Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults-a systematic review and meta-analysis
Udo Holtick et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis
Norbert-Claude Gorin et al.
HAEMATOLOGICA (2015)
T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis
Norbert-Claude Gorin et al.
HAEMATOLOGICA (2015)
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
J. J. Cornelissen et al.
LEUKEMIA (2015)
Donor Lymphocyte Infusion for the Treatment of Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
Akiyoshi Takami et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Post-remission therapy for acute myeloid leukemia
Richard F. Schlenk
HAEMATOLOGICA (2014)
Unrelated Donor Allogeneic Transplantation after Failure of Autologous Transplantation for Acute Myelogenous Leukemia: A Study from the Center for International Blood and Marrow Transplantation Research
James M. Foran et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA
Richard F. Schlenk et al.
BLOOD (2013)
The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML
Nona Shayegi et al.
BLOOD (2013)
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
Roland B. Walter et al.
BLOOD (2013)
Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia
S. A. Buckley et al.
BONE MARROW TRANSPLANTATION (2013)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation
Dario Campana et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research
Armand Keating et al.
HAEMATOLOGICA (2013)
Acute Myeloid Leukemia in First Remission: To Choose Transplantation or Not?
Richard M. Stone
JOURNAL OF CLINICAL ONCOLOGY (2013)
Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission
Alan K. Burnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The performance of different propensity score methods for estimating marginal hazard ratios
Peter C. Austin
STATISTICS IN MEDICINE (2013)
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: A GOELAMS study
Romain Guieze et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2012)
Comparison of Autologous Hematopoietic Cell Transplantation and Chemotherapy as Postremission Treatment in Non-M3 Acute Myeloid Leukemia in First Complete Remission
Kensuke Usuki et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial
Markus Pfirrmann et al.
LANCET ONCOLOGY (2012)
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Claudio Anasetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study
Shigeki Ohtake et al.
BLOOD (2011)
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin
Hugo F. Fernandez et al.
BLOOD (2011)
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial
Theo de Witte et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
Koji Nagafuji et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
Sergio Giralt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Higher Incidence of Relapse With Peripheral Blood Rather Than Marrow As a Source of Stem Cells in Adults With Acute Myelocytic Leukemia Autografted During the First Remission
Norbert-Claude Gorin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Autologous Stem Cell Transplantation with PCR-Negative Graft Would Be Associated with a Favorable Outcome in Core-Binding Factor Acute Myeloid Leukemia
Hideki Nakasone et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): A retrospective study from the European Cooperative Group for Blood and Marrow Transplantation
Norbert-Claude Gorin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Toward Optimization of Postremission Therapy for Residual Disease-Positive Patients With Acute Myeloid Leukemia
Luca Maurillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Donor lymphocyte infusion in the treatment of first Hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia:: A retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system
Yoshiko Atsuta et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Competing risk analysis using R: an easy guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2007)
Long-term follow-up of Asian patients younger than 46 years with acute myeloid leukemia in first complete remission: comparison of allogeneic vs. autologous hematopoietic stem cell transplantation
Yvonne Su Ming Loh et al.
LEUKEMIA & LYMPHOMA (2007)
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia
A-L Herr et al.
LEUKEMIA (2007)
FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation
G Yoshimoto et al.
BONE MARROW TRANSPLANTATION (2005)
Prognostic index for adult patients with acute myeloid leukemia in first relapse
DA Breems et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial
DA Breems et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: A meta-analysis
PC Nathan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission
I Levi et al.
LEUKEMIA RESEARCH (2004)
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CRI): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial
S Suciu et al.
BLOOD (2003)
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia:: disease status by marrow blasts is the strongest prognostic factor
HG Sayer et al.
BONE MARROW TRANSPLANTATION (2003)
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
A Venditti et al.
LEUKEMIA (2003)
Autologous stem cell transplantation for acute myeloid leukemia in first remission
CA Linker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
